RE: maybe of interest1 Feb 2022 18:34
2 of 2
Having evolved from this AI diagnostics technology, a breath test ‘Microtox BT’, is now in the testing/approval stage - further news is expected any time Q1 2022. This could be a game changer for Covid monitoring and testing in the future, especially for large venues and cruise ships
Cosmetics and Skin
Through Labskin, Deepverge offers the only commercially available lab-grown, full thickness human skin model with AI assisted testing platform. This is currently used by a growing number of cosmetics companies to test products, preferring this option over that of testing on living animals.
Deepverge offer an additional service to clients Skin Trust Club, identifying their skin biome so they can better understand its needs and requirements, by monitoring and testing individuals using advanced sequencing, bioinformatics and AI Algorithms. STC has rapidly accumulated over 30,000 registered members, some 58% of which have underlying skin conditions, suggesting DeepVerge has identified a significant international, longer-term unmet consumer need. DV are clearly confident of further growth having increased its processing capacity heading into 2022, to 20,000/month in each of the UK, Ireland and US laboratories. Additional capacity to substantially expand this in response to spiking demand can be brought quickly on-stream.
Working hand in glove with the cosmetics industry business, it recommends products suitable to individual skin type, with global expansion providing access to a growing list of household names including Unilever, L’Oréal, Estee Lauder, Walgreens Boots Alliance, Amway and L’Occitane. Deepverge's STC has recently won awards for best new skin innovation and is fast becoming a recognised brand in the cosmetics world.
One of the greatest attractions for this company is its CEO Svengali Gerard Brandon who has a history of pairing mutually beneficial companies and bringing them to profitability. His vision here has brought together Modern Water, Rinocloud (AI), and Labskin into the Deepverge family, and used the miniaturisation capacity of Microsaic PLC (on which board he currently sits) to create uniquely commercial diagnostic equipment. He has also forged ahead with the biotech Skin products. He seems to me like a man addicted to ideas.
Of course this isn’t the only undervalued stock on the UK AIM (LSE) right now. It, among others, has remained unloved during 2021 as many investors are attracted to the bright lights of the big US tech stock. But I believe it’s likely to have its day soon enough and then the true valuation across the board will be recognised. Right now Deepverge is at a bargain basement price and with a number of news releases expected in Q1 of 2022 now might be a good time to get in.